- Report
- May 2026
- 280 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- January 2026
- 180 Pages
Global
From €4007EUR$4,500USD£3,495GBP
- Report
- January 2026
- 185 Pages
Global
From €4007EUR$4,500USD£3,495GBP
- Report
- June 2025
- 150 Pages
Global
From €2404EUR$2,699USD£2,096GBP
- Report
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,166GBP
- Report
- March 2026
- 197 Pages
Global
From €4448EUR$4,995USD£3,879GBP
- Report
- August 2025
- 150 Pages
Global
From €4319EUR$4,850USD£3,766GBP
- Report
- July 2025
- 150 Pages
Global
From €4319EUR$4,850USD£3,766GBP
- Report
- February 2026
- 160 Pages
Global
From €2957EUR$3,320USD£2,578GBP
€3696EUR$4,150USD£3,223GBP
- Report
- February 2026
- 191 Pages
Global
From €4448EUR$4,995USD£3,879GBP
- Report
- February 2026
- 200 Pages
Global
From €4448EUR$4,995USD£3,879GBP
- Report
- May 2025
- 134 Pages
Global
From €16025EUR$17,995USD£13,974GBP
- Report
- March 2026
- 177 Pages
Global
From €16025EUR$17,995USD£13,974GBP
- Report
- August 2025
- 98 Pages
Global
From €4319EUR$4,850USD£3,766GBP
- Report
- May 2026
- 50 Pages
Global
From €2360EUR$2,650USD£2,058GBP
- Report
- May 2026
- 50 Pages
Global
From €2360EUR$2,650USD£2,058GBP
- Report
- May 2026
- 50 Pages
Global
From €2360EUR$2,650USD£2,058GBP
- Report
- May 2026
- 50 Pages
Global
From €2360EUR$2,650USD£2,058GBP
- Report
- May 2026
- 50 Pages
Global
From €2360EUR$2,650USD£2,058GBP
- Report
- January 2026
Global
From €6679EUR$7,500USD£5,824GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more